These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 18838745)

  • 1. Non--AIDS-defining malignancies in HIV.
    Mitsuyasu RT
    Top HIV Med; 2008; 16(4):117-21. PubMed ID: 18838745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-AIDS-defining cancers.
    Stebbing J; Duru O; Bower M
    Curr Opin Infect Dis; 2009 Feb; 22(1):7-10. PubMed ID: 19532075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals.
    Burgi A; Brodine S; Wegner S; Milazzo M; Wallace MR; Spooner K; Blazes DL; Agan BK; Armstrong A; Fraser S; Crum NF
    Cancer; 2005 Oct; 104(7):1505-11. PubMed ID: 16104038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AIDS-defining and non-AIDS-defining malignancies: cancer occurrence in the antiretroviral therapy era.
    Silverberg MJ; Abrams DI
    Curr Opin Oncol; 2007 Sep; 19(5):446-51. PubMed ID: 17762569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV infection and cancer in the era of highly active antiretroviral therapy (Review).
    Barbaro G; Barbarini G
    Oncol Rep; 2007 May; 17(5):1121-6. PubMed ID: 17390054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients.
    Herida M; Mary-Krause M; Kaphan R; Cadranel J; Poizot-Martin I; Rabaud C; Plaisance N; Tissot-Dupont H; Boue F; Lang JM; Costagliola D
    J Clin Oncol; 2003 Sep; 21(18):3447-53. PubMed ID: 12972519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of AIDS-defining cancers and virus-related and non-virus-related non-AIDS-defining cancers among HIV-infected patients compared with the general population in a large health district of Northern Italy, 1999-2009.
    Calabresi A; Ferraresi A; Festa A; Scarcella C; Donato F; Vassallo F; Limina R; Castelli F; Quiros-Roldan E;
    HIV Med; 2013 Sep; 14(8):481-90. PubMed ID: 23560682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-AIDS-defining cancers: should antiretroviral therapy be initiated earlier?
    Cinti SK; Gandhi T; Riddell J
    AIDS Read; 2008 Jan; 18(1):18-20, 26-32. PubMed ID: 18240449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on cardiovascular complications in HIV infection.
    Currier JS
    Top HIV Med; 2009; 17(3):98-103. PubMed ID: 19675367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolving epidemiology of malignancies in HIV.
    Bonnet F; Chêne G
    Curr Opin Oncol; 2008 Sep; 20(5):534-40. PubMed ID: 19106656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection.
    Powles T; Robinson D; Stebbing J; Shamash J; Nelson M; Gazzard B; Mandelia S; Møller H; Bower M
    J Clin Oncol; 2009 Feb; 27(6):884-90. PubMed ID: 19114688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AIDS-related malignancies: revisited.
    Cáceres W; Cruz-Amy M; Díaz-Meléndez V
    P R Health Sci J; 2010 Mar; 29(1):70-5. PubMed ID: 20222338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The growing problem of non-AIDS-defining malignancies in HIV.
    Pantanowitz L; Schlecht HP; Dezube BJ
    Curr Opin Oncol; 2006 Sep; 18(5):469-78. PubMed ID: 16894295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prevalence of posttransplantation cancers compared with cancers in people with human immunodeficiency virus/acquired immunodeficiency syndrome after highly active antiretroviral therapy.
    Srisawat N; Avihingsanon A; Praditpornsilpa K; Jiamjarasrangsi W; Eiam-Ong S; Avihingsanon Y
    Transplant Proc; 2008 Oct; 40(8):2677-9. PubMed ID: 18929833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of highly active antiretroviral therapy on non-AIDS-defining cancers among adults with AIDS.
    Hessol NA; Pipkin S; Schwarcz S; Cress RD; Bacchetti P; Scheer S
    Am J Epidemiol; 2007 May; 165(10):1143-53. PubMed ID: 17344204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV disease progression: immune activation, microbes, and a leaky gut.
    Douek D
    Top HIV Med; 2007; 15(4):114-7. PubMed ID: 17720995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Burden of non-AIDS-defining and non-virus-related cancers among HIV-infected patients in the combined antiretroviral therapy era.
    Albini L; Calabresi A; Gotti D; Ferraresi A; Festa A; Donato F; Magoni M; Castelli F; Quiros-Roldan E
    AIDS Res Hum Retroviruses; 2013 Aug; 29(8):1097-104. PubMed ID: 23581483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [AIDS associated cancers in the era of highly active antiretroviral therapy (HAART)].
    Tserenpuntsag B; Kołacińska A; Jabłonowska E
    Przegl Epidemiol; 2007; 61(3):529-34. PubMed ID: 18069390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-AIDS-defining cancers.
    Mitsuyasu RT
    Top Antivir Med; 2014; 22(3):660-5. PubMed ID: 25101532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung cancer, a new challenge in the HIV-infected population.
    Lavolé A; Wislez M; Antoine M; Mayaud C; Milleron B; Cadranel J
    Lung Cancer; 2006 Jan; 51(1):1-11. PubMed ID: 16300854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.